-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BZuKSkO3gX+e9AF+29fjQFvVSG4aLcV/NogrCzM18CjIziqAsvnsxiq9ZCbvFTs/ +0audxaZUt4POtGKi545tg== 0001209191-10-029322.txt : 20100520 0001209191-10-029322.hdr.sgml : 20100520 20100520162517 ACCESSION NUMBER: 0001209191-10-029322 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20091112 FILED AS OF DATE: 20100520 DATE AS OF CHANGE: 20100520 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CAVANAUGH JAMES H CENTRAL INDEX KEY: 0001013473 STATE OF INCORPORATION: DE FISCAL YEAR END: 0731 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-29173 FILM NUMBER: 10848193 MAIL ADDRESS: STREET 1: 44 NASSAU ST CITY: PRINCETON STATE: NJ ZIP: 08542 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERENIUM CORP CENTRAL INDEX KEY: 0001049210 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 223297375 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617 674 5300 MAIL ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: DIVERSA CORP DATE OF NAME CHANGE: 19991201 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0303 4/A 2009-11-12 2009-11-16 0 0001049210 VERENIUM CORP VRNM 0001013473 CAVANAUGH JAMES H 44 NASSAU STREET PRINCETON NJ 08542 1 0 0 0 Option (Right to Buy) 7.1472 2009-11-12 4 D 0 2917 0.00 D 2019-09-02 Common Stock 2917 0 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 1157 A 2019-11-12 Common Stock 1157 1157 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 208 A 2019-11-12 Common Stock 208 208 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 208 A 2019-11-12 Common Stock 208 208 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 1458 A 2019-11-12 Common Stock 1458 1458 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 1458 A 2019-11-12 Common Stock 1458 1458 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 1388 A 2019-11-12 Common Stock 1389 1389 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 1458 A 2019-11-12 Common Stock 1458 1458 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 2916 A 2019-11-12 Common Stock 2916 2916 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 2916 A 2019-11-12 Common Stock 2916 2916 D Option (Right to Buy) 3.85 2009-11-12 4 A 0 2917 A 2019-11-12 Common Stock 2917 2917 D Please note that the acquisition of this option was reported on an intervening report on Form 4 filed with the Securities and Exchange Commission on January 5, 2010. This option was cancelled in exchange for new options to purchase shares of common stock at an exercise price of $3.85 per share pursuant to the Issuer's stock option exchange program which commenced on October 13, 2009 and terminated on November 12, 2009. This exchange transaction that was inadvertently omitted from the original Form 4 filing. Reflects a 12-for-1 reverse stock split effective on September 9, 2009 Cancelled in exchange for new options to purchase shares of common stock at an exercise price of $3.85 per share pursuant to the Issuer's stock option exchange program which commenced on October 13, 2009 and terminated on November 12, 2009. This option vests and becomes exercisable in 36 equal monthly installments commencing on 10/2/2009. This Form 4A is being filed to correct the previously reported vesting schedules for options granted as part of the Issuer's stock option exchange program that commenced on October 13, 2009 and terminated on November 12, 2009. Granted in exchange for options surrendered (as reported above) pursuant to the Issuer's stock option exchange program which commenced on October 13, 2009 and terminated on November 12, 2009. One-half of these shares vested on November 12, 2009. The remaining shares vest in equal quarterly installments over the next consecutive 12 quarters. This option shall vest according to the following schedule: (i) 891 options vested on November 12, 2009, the date of grant; (ii) 929 options shall vest and become exercisable in equal quarterly installments beginning on December 7, 2009 and ending on December 7, 2010; and (iii) the remaining 1,096 options shall vest and become exercisable in equal quarterly installments begining on March 7, 2011 and becoming fully vested on December 7, 2013. This option shall vest according to the following schedule: (i) 284 options vested on November 12, 2009, the date of grant; (ii) 1,792 options shall vest and become exercisable in equal quarterly installments beginning on November 13, 2009 and ending on February 13, 2012; and (iii) the remaining 840 options shall vest and become exercisable in equal quarterly installments beginning on May 13, 2012 and becoming fully vested on February 13, 2015. This option shall vest according to the following schedule: (i) 82 options vested on November 12, 2009, the date of grant; (ii) 2,097 options shall vest and become exercisable in equal quarterly installments beginning on December 2, 2009 and ending on September 2, 2012; and (iii) the remaining 738 options shall vest and become exercisable in equal quarterly installments beginning on December 2, 2012 becoming fully vested on September 2, 2015. /s/Jeffrey Steinberg, Attorney-in-Fact for James Cavanaugh 2010-05-19 -----END PRIVACY-ENHANCED MESSAGE-----